The reports are unverified, and one names a 'research use only' vendor. Poison centers logged 862 retatrutide exposures in three months, CBS says.
Recap by typeshit. Full story at CBS News.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
In a 575-user study across four countries, 39% reported nails lifting versus 9% of controls. A companion study also found more hair loss and scalp redness.
Gallup estimates 11% of US adults used GLP-1s for weight loss in 2026, up from 3% in 2024, and food makers are reworking protein, fiber and portion sizes.
Loading…